A new healthcare investment landscape is emerging marked by fewer deals, slower investment pace, smaller check sizes and more scrutinous investors. Yet, there are reasons for optimism. The rightsizing of valuations is leading to more sustainable, long-term growth and profitability targets. Venture fundraising rebounded, with investors sitting on record capital for right-sized investment into the healthcare innovation economy.